Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05929794 · ClinicalTrials.gov registry record · Phase 4
Pharmacokinetics of Transdermal Metronidazole
A Phase 4 study of Healthy, sponsored by University of Iowa.
- Active
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT05929794 is a Phase 4 study of Healthy that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 24 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05929794, a Phase 4 study of Healthy, is active but no longer recruiting, sponsored by University of Iowa.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a crossover pharmacokinetic clinical study in healthy volunteers to compare metronidazole delivery through skin when a gel or cream metronidazole product is applied to skin treated with a micropatch.
Conditions Studied
Interventions
- DRUG Metronidazole 0.75% Topical Gel
- DRUG Metronidazole 0.75% Topical Cream
- DIAGNOSTIC_TEST Transdermal water loss measurement
- DIAGNOSTIC_TEST Electrical Resistance
- DIAGNOSTIC_TEST Skin color measurement
Study Locations (1)
Iowa
- University of Iowa - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05929794
The ClinicalTrials.gov registry entry for NCT05929794 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (96% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 5 interventions - of which Metronidazole 0.75% Topical Gel is the first listed.
NCT05929794 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT05929794 about?
NCT05929794 is a clinical study titled "Pharmacokinetics of Transdermal Metronidazole". This is a crossover pharmacokinetic clinical study in healthy volunteers to compare metronidazole delivery through skin when a gel or cream metronidazole product is applied to skin treated with a micropatch.
What is the current status of trial NCT05929794?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 2024-02-26. Estimated completion is 2026-12.
What conditions does trial NCT05929794 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT05929794?
The interventions under investigation include: Metronidazole 0.75% Topical Gel (DRUG), Metronidazole 0.75% Topical Cream (DRUG), Transdermal water loss measurement (DIAGNOSTIC_TEST), Electrical Resistance (DIAGNOSTIC_TEST), Skin color measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05929794?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05929794 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation
RECRUITING · Phase 4
-
Effects of GH and Lirglutide on AgRP
RECRUITING · Phase 4
-
Effects of Caffeine on Reinforcement Learning in Healthy Adults Using PET/MRI
RECRUITING · Phase 4
-
Endothelial Derived Hyperpolarization Factor and Vascular Control
RECRUITING · Phase 4
-
Glucagon Suppression by Hyperglycemia in the Presence and Absence of Amino Acid Infusion
ACTIVE NOT RECRUITING · Phase 4
-
VO2 Max: In Vivo Model for Functional Red Cell Testing. Can RECESS be Explained?
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.